EVIDENCE FOR POLYMORPHIC OXIDATION OF SPARTEINE IN JAPANESE SUBJECTS

被引：58

作者：

ISHIZAKI, T

EICHELBAUM, M

HORAI, Y

HASHIMOTO, K

CHIBA, K

DENGLER, HJ

机构：

[1] YAMANASHI MED COLL,DEPT PHARMACOL,KOFU,JAPAN

[2] UNIV BONN,DEPT MED,D-5300 BONN,FED REP GER

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 23卷 / 04期

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03080.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：482 / 485

页数：4

相关论文

共 16 条

[1] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
BERTILSSON, L
DENGLER, HJ
EICHELBAUM, M
SCHULZ, HU
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
[2] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS
CLARK, DWJ
[J]. DRUGS, 1985, 29 (04) : 342 - 375
[3] INTER-ETHNIC DIFFERENCE IN SPARTEINE OXIDATION AMONG GHANAIANS AND GERMANS
EICHELBAUM, M
WOOLHOUSE, NM
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (01) : 79 - 83
[4] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT
EICHELBAUM, M
SPANNBRUCKER, N
STEINCKE, B
DENGLER, HJ
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) : 183 - 187
[5] THE GENETIC-POLYMORPHISM OF SPARTEINE METABOLISM
EICHELBAUM, M
REETZ, KP
SCHMIDT, EK
ZEKORN, C
[J]. XENOBIOTICA, 1986, 16 (05) : 465 - 481
[6] POLYMORPHIC OXIDATION OF SPARTEINE AND DEBRISOQUINE - RELATED PHARMACOGENETIC ENTITIES
EICHELBAUM, M
BERTILSSON, L
SAWE, J
ZEKORN, C
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (02) : 184 - 186
[7] EICHELBAUM M, 1984, FED PROC, V43, P2298
[8] EICHELBAUM M, 1982, CLIN PHARMACOKINET, V7, P1, DOI 10.2165/00003088-198207010-00001
[9] IDLE JR, 1984, 2ND P WORLD C CLIN P, P148
[10] DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE
INABA, T
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 547 - 549